A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Name: A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection
License: Public Domain

Janssen Vaccines & Prevention B.V.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

respiratory syncytial virus infection prevention

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405190
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.